AIN

Analyst Note: Albany International Corp. (AIN)

Date: 2026-06-13 Current Price: $71.08

1. Structural Readiness

State: Forming Conservative Entry: — (Awaiting confirmed breakout above the coil high) Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone; requires confirmation) Breakout Level: — (Defined by the high of the current consolidation range; not yet breached) Current Price: $71.08 Extension: — (Price is currently within the consolidation range, not extended above the breakout level) ATR Context: Current ATR is 3.3% (Productive). This sits within the historical "sweet spot" (4–6% is ideal, but 3.3% indicates manageable volatility for a forming structure).

2. Thesis Layer

Primary Secular Thesis: Defense Modernization (Precision Munitions). Role & Directness: Albany International is a direct beneficiary of the U.S. government's push for increased missile production. Management explicitly stated in the Q2 2026 earnings transcript that they have been requested to increase production of JASSM and LRASM missiles to the "highest level achievable within our current capabilities," including through overtime. This places AIN at the center of a critical supply chain bottleneck being actively resolved by the Department of Defense. Secondary Secular Themes:

• Critical Minerals & Materials (Specialty & Advanced Materials): The company's proprietary 3D weaving and composite technologies serve as a critical replacement for titanium in defense and commercial applications, addressing industrial base constraints.
• Commercial Aerospace Recovery: The AEC segment is ramping up production on the LEAP engine program (SAFRAN/CFM International), capturing volume lost during previous production halts.

Conviction Weighting: The convergence of a direct defense mandate (missile volume) and a commercial aerospace recovery (LEAP engine) creates a dual-engine growth profile. The defense component provides immediate volume certainty, while the commercial component offers longer-term margin expansion as the LEAP program stabilizes.

3. Business Overview

Albany International Corp. operates two primary segments: Machine Clothing (MC) and Albany Engineered Composites (AEC).

• Albany Engineered Composites (AEC): This segment is the primary growth driver. It manufactures advanced 3D-woven and injected composite components for aircraft engines, airframes, and defense systems.
• Defense: AEC is a key supplier for precision munitions (JASSM, LRASM). As of Q2 2026, management confirmed they are operating at maximum capacity for these programs.
• Commercial Aerospace: AEC is the exclusive supplier of advanced composite fan blades and cases for the CFM International LEAP engine via its ASC subsidiary. Sales to SAFRAN (the primary customer for LEAP) accounted for approximately 15% of consolidated net revenues in 2025.
• Recent Developments: In Q4 2025, AEC secured a new contract with Pratt & Whitney for composite engine components for the Geared Turbofan engine.
• Financial Performance: Net revenues for the three months ended March 31, 2026, increased 27.4% year-over-year, driven by higher activity on ASC, GE LEAP Platforms, and B787 Frames.

• Machine Clothing (MC): This segment provides specialized paper machine clothing and technical textiles for paper, tissue, and industrial applications.
• Performance: Packaging and tissue products continue to perform well. However, publication grade paper demand remains under structural pressure, with management expecting this decline to continue through 2026 and beyond.
• Strategic Review: Management announced in Q4 2025 a strategic review of the Amelia Earhart Drive facility in Salt Lake City, which houses CH-53K contract work. The review is expected to conclude by the end of 2026, with an expectation of a sale of the facility and associated work.

• Financial Position: As of March 31, 2026, the company held $122.6 million in cash and cash equivalents with $323.5 million in borrowing capacity, totaling approximately $446.0 million in liquidity.

4. Archetype and Conviction

Archetype: Growth Leader (with elements of Cyclical Recovery). Fit: The company fits the "Growth Leader" archetype due to the structural inflection in its AEC segment. The transition from production constraints to "highest level achievable" output, combined with new commercial contracts (Pratt & Whitney) and the recovery of the LEAP program, signals a clear inflection point in earnings power. The MC segment acts as a cash-flow stabilizer, though it faces secular headwinds in publication grades.

Valuation & Conviction Stack:

• Thesis Strength: High. The defense mandate is explicit and immediate (Q2 2026 transcript).
• Evidence Quality: Strong. Multiple primary sources (earnings transcripts, 10-K/10-Q filings) confirm volume increases, new contracts, and capacity utilization.
• Structural Quality: The AEC segment is capturing value from both defense (high margin, government-backed) and commercial (high volume, long-term contracts) sectors.
• Rerating Potential: Significant. The market is currently pricing in the recovery, but the full realization of the "highest level achievable" missile production and the new Pratt & Whitney contract may drive a re-rating as earnings catch up to the guidance.
• Financial Spine: Forward consensus EPS for FY1 is $2.65 and FY2 is $3.15, indicating a clear path to earnings growth.

5. Invalidations, Strengtheners, and Gaps

What Would Invalidate the Case:

• Operational Failure: A significant delay in the strategic review of the Salt Lake City facility that results in the retention of a loss-making asset, or a failure to secure the expected volume from the Pratt & Whitney contract.
• Defense Budget Cuts: A sudden reduction in U.S. government defense spending specifically targeting precision munitions (JASSM/LRASM) would directly impact the primary growth driver.

What Would Strengthen the Case:

• Breakout Confirmation: A daily close above the high of the current consolidation range (breakout level) would confirm the "Forming" coil into a "Confirmed" setup.
• Guidance Raise: Management raising Q3 or full-year revenue/EPS guidance above the current ranges ($335M-$345M revenue, $0.70-$0.80 EPS) would validate the "highest level achievable" narrative.
• Facility Sale Completion: Successful execution of the Salt Lake City facility sale by the end of 2026 would unlock capital and remove a non-core asset drag.

Gaps in Evidence:

• Specific Margin Data: While revenue growth is confirmed, specific margin expansion data for the new Pratt & Whitney contract is not detailed in the provided evidence.
• Timeline for Salt Lake City Sale: The exact timing and proceeds of the facility sale are expected to be completed by end of 2026, but the specific financial impact is not yet quantified in the current filings.

PRIVATE ANALYST CALL Judgment: Buy Confidence: medium Key evidence: Management confirmed request to increase JASSM/LRASM production to highest achievable levels; AEC net revenues up 27.4% YoY driven by LEAP and defense programs; New Pratt & Whitney contract secured for Geared Turbofan components. Key risks: Publication grade paper demand continues to decline structurally; Strategic review of Salt Lake City facility may result in unexpected costs or delays; Defense budget reallocations could impact missile production rates. Sizing hint: Position size should reflect the "Forming" setup status; allocate based on conviction in the thesis but maintain flexibility for the breakout confirmation. Expected path: Management expects to recover lost volume by end of 2026; AEC segment ramps production on new contracts; MC segment stabilizes with tissue growth offsetting publication declines. Expected horizon: 12 to 18 months for the full thesis to play out as production ramps and facility review concludes.